Skip to main content
Exact Dx synthetic data · demonstration

Staff surface Definitions and reviews

Definition library

Every executable definition and catalogue entry, with the threshold quoted from its source. All are drafts pending clinical and coding review; a definition shows as reviewed only after an approval is recorded. Default set library_default_set@1.0.

Coder worklist

Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default

CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.

Current: Off (default) When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never raise a "not stated" item.

CDI or coding staff can change this setting and record reviews: switch the demo user.

1 of 66 shown.

Diabetes diagnostic thresholds and the confirmation rule (ADA Standards of Care 2026) ada2026_diabetes@1.0 1 Draft · pending review draft — pending clinical and coding review
Status
draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition
Diabetes mellitus
Tier
1
Use here
default set (diabetes)
Edition
Standards of Care in Diabetes—2026 (2026)
Second source
none opened · not found: The WHO diabetes fact sheet (dated 11 November 2026) states no numeric thresholds; the WHO 2006/2011 reports were not opened. No independent second source was opened.
Contested
no: ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).

American Diabetes Association Professional Practice Committee, 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026

ada2026_diabetes@1.0
Table 2.1: A1C ≥6.5% (≥48 mmol/mol); FPG ≥126 mg/dL (≥7.0 mmol/L); 2-h PG ≥200 mg/dL (≥11.1 mmol/L) during OGTT; random plasma glucose ≥200 mg/dL (≥11.1 mmol/L) with classic symptoms of hyperglycemia or hyperglycemic crisis. In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from different tests ... or the same test at two different time points.

Standards of Care in Diabetes—2026 (2026) · Table 2.1 Criteria for the diagnosis of diabetes in nonpregnant individuals · source

Review

No review recorded yet.